CRPS Tag

CRPS-RISE

Why CRPS-RISE? CRPS-RISE (NCT07210515) is a Phase 3 randomized, triple-blind, placebo-controlled clinical trial evaluating neridronate as a potential new treatment option for Complex Regional Pain Syndrome Type 1 (CRPS-1), a rare and debilitating condition with an annual incidence of ~65,0001 and currently no FDA-approved medicine in...